Dentsply Sirona
DENTSPLY SIRONA Inc.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$3.7B
Operating marginCalculated
-11.5%
Net assets to total assetsCalculated
24.7%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★☆☆☆☆position among all companies
-11.5%
Growth (revenue, 4-year average)
★☆☆☆☆position among all companies
-3.4%
Capital efficiency
★☆☆☆☆position among all companies
-44.7%
Revenue and profit
Performance, financial position and capital allocation
Dentsply Sirona
Recent performance trends
Dentsply Sirona
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$4.2 billion | US$3.9 billion | US$4.0 billion | US$3.8 billion | US$3.7 billion |
| Operating income | US$0.6 billion | US$-0.9 billion | US$-85.00 million | US$-0.9 billion | US$-0.4 billion |
| Net income | US$0.4 billion | US$-0.9 billion | US$-0.1 billion | US$-0.9 billion | US$-0.6 billion |
| Total assets | US$9.2 billion | US$7.6 billion | US$7.4 billion | US$5.8 billion | US$5.4 billion |
| Shareholders' equity | US$5.0 billion | US$3.8 billion | US$3.3 billion | US$1.9 billion | US$1.3 billion |
| Net cash provided by (used in) operating activities | US$0.7 billion | US$0.5 billion | US$0.4 billion | US$0.5 billion | US$0.2 billion |
| Net cash provided by (used in) investing activities | US$-0.4 billion | US$-0.1 billion | US$-89.00 million | US$-0.2 billion | US$-0.1 billion |
| Net cash provided by (used in) financing activities | US$-0.4 billion | US$-0.3 billion | US$-0.3 billion | US$-0.3 billion | US$-80.00 million |
| Cash and cash equivalents | US$0.3 billion | US$0.4 billion | US$0.3 billion | US$0.3 billion | US$0.3 billion |
Revenue scale in the same industry
Dentsply Sirona
Instruments and medical devices: 43 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Thermo Fisher ScientificFY Dec 2025 US$44.6B
- 2 Northrop Grumman Corp /DE/FY Dec 2025 US$42.0B
- 3 MedtronicFY Apr 2026 US$36.4B
- … 31 companies
- 35 Mettler-Toledo InternationalFY Dec 2025 US$4.0B
- 36 MKSFY Dec 2025 US$3.9B
- 37 Dentsply SironaThis companyFY Dec 2025 US$3.7B
- 38 Leonardo DRSFY Dec 2025 US$3.6B
- 39 TrimbleFY Jan 2026 US$3.6B
- … 4 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.1 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-80.00 million | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.1 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.2 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.4 billion | Consolidated | Disclosed |
| Dividends paid | US$0.1 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$1.3 billion | Consolidated | Disclosed |
| Non-controlling interests | US$1.00 million | Consolidated | Disclosed |
| Net assets | US$1.3 billion | Consolidated | Disclosed |
| Net sales | US$3.7 billion | Consolidated | Disclosed |
| Operating income | US$-0.4 billion | Consolidated | Disclosed |
| Net income | US$-0.6 billion | Consolidated | Disclosed |
| Total assets | US$5.4 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0 | Consolidated | Disclosed |
| Operating margin | -11.5% | Consolidated | Calculated |
| Net assets to total assets | 24.7% | Consolidated | Calculated |
| Net margin | -16.2% | Consolidated | Calculated |
| Return on equity | -44.7% | Consolidated | Calculated |